These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 32260240)

  • 1. A Self-Calibrating IoT Portable Electrochemical Immunosensor for Serum Human Epididymis Protein 4 as a Tumor Biomarker for Ovarian Cancer.
    Bianchi V; Mattarozzi M; Giannetto M; Boni A; De Munari I; Careri M
    Sensors (Basel); 2020 Apr; 20(7):. PubMed ID: 32260240
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Electrochemical immunomagnetic assay as biosensing strategy for determination of ovarian cancer antigen HE4 in human serum.
    Mattarozzi M; Giannetto M; Careri M
    Talanta; 2020 Sep; 217():120991. PubMed ID: 32498877
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cooperative amplification of Prussian blue as a signal indicator and functionalized metal-organic framework-based electrochemical biosensor for an ultrasensitive HE4 assay.
    Xu X; Tang L; Yu Y; Zhang J; Zhou X; Zhou T; Xuan C; Tian Q; Pan D
    Biosens Bioelectron; 2024 Oct; 262():116541. PubMed ID: 38959719
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An ultrasensitive ratiometric electrochemiluminescence immunosensor combining photothermal amplification for ovarian cancer marker detection.
    Fang D; Zhang S; Dai H; Lin Y
    Biosens Bioelectron; 2019 Dec; 146():111768. PubMed ID: 31606687
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Electrochemical quantum dots-based magneto-immunoassay for detection of HE4 protein on metal film-modified screen-printed carbon electrodes.
    Cadkova M; Kovarova A; Dvorakova V; Metelka R; Bilkova Z; Korecka L
    Talanta; 2018 May; 182():111-115. PubMed ID: 29501129
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Coupling metal-organic framework nanosphere and nanobody for boosted photoelectrochemical immunoassay of Human Epididymis Protein 4.
    Chen K; Xue J; Zhou Q; Zhang Y; Zhang M; Zhang Y; Zhang H; Shen Y
    Anal Chim Acta; 2020 Apr; 1107():145-154. PubMed ID: 32200889
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detection of serum human epididymis secretory protein 4 in patients with ovarian cancer using a label-free biosensor based on localized surface plasmon resonance.
    Yuan J; Duan R; Yang H; Luo X; Xi M
    Int J Nanomedicine; 2012; 7():2921-8. PubMed ID: 22745553
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neutral Charged Immunosensor Platform for Protein-based Biomarker Analysis with Enhanced Sensitivity.
    Dai Y; Chiu LY; Chen Y; Qin S; Wu X; Liu CC
    ACS Sens; 2019 Jan; 4(1):161-169. PubMed ID: 30582808
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical Usefulness of Cancer Antigen (CA) 125, Human Epididymis 4, and CA72-4 Levels and Risk of Ovarian Malignancy Algorithm Values for Diagnosing Ovarian Tumors in Korean Patients With and Without Endometriosis.
    Shin KH; Kim HH; Kwon BS; Suh DS; Joo JK; Kim KH
    Ann Lab Med; 2020 Jan; 40(1):40-47. PubMed ID: 31432638
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ultrasensitive immunoassay of carcinoma antigen 125 in untreated human plasma samples using gold nanoparticles with flower like morphology: A new platform in early stage diagnosis of ovarian cancer and efficient management.
    Hasanzadeh M; Sahmani R; Solhi E; Mokhtarzadeh A; Shadjou N; Mahboob S
    Int J Biol Macromol; 2018 Nov; 119():913-925. PubMed ID: 30081127
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnostic accuracy of CA125 and HE4 in ovarian carcinoma patients and the effect of confounders on their serum levels.
    Ahmed AA; Abdou AM
    Curr Probl Cancer; 2019 Oct; 43(5):450-460. PubMed ID: 30670303
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Making new biomarkers a reality: the case of serum human epididymis protein 4.
    Ferraro S; Panteghini M
    Clin Chem Lab Med; 2019 Aug; 57(9):1284-1294. PubMed ID: 30511925
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnostic Performance of Serum Human Epididymis Protein 4 (HE4) for Prediction of Malignancy in Ovarian Masses.
    Dewan R; Dewan A; Jindal M; Bhardawaj M
    Asian Pac J Cancer Prev; 2019 Apr; 20(4):1103-1108. PubMed ID: 31030480
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An SPRi Biosensor for Determination of the Ovarian Cancer Marker HE4 in Human Plasma.
    Szymanska B; Lukaszewski Z; Zelazowska-Rutkowska B; Hermanowicz-Szamatowicz K; Gorodkiewicz E
    Sensors (Basel); 2021 May; 21(10):. PubMed ID: 34065481
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Performance of preoperative plasma tumor markers HE4 and CA125 in predicting ovarian cancer mortality in women with epithelial ovarian cancer.
    Furrer D; Grégoire J; Turcotte S; Plante M; Bachvarov D; Trudel D; Têtu B; Douville P; Bairati I
    PLoS One; 2019; 14(6):e0218621. PubMed ID: 31220149
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The use of aggregation-induced emission probe doped silica nanoparticles for the immunoassay of human epididymis protein 4.
    Meng L; Nawaz MAH; Huang X; Ma Y; Li Y; Zhou H; Yu C
    Analyst; 2019 Oct; 144(20):6136-6142. PubMed ID: 31536063
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The power of the Risk of Ovarian Malignancy Algorithm considering menopausal status: a comparison with CA 125 and HE4.
    Han KH; Park NH; Kim JJ; Kim S; Kim HS; Lee M; Song YS
    J Gynecol Oncol; 2019 Nov; 30(6):e83. PubMed ID: 31576682
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ultrasensitive bioassay of epitope of Mucin-16 protein (CA 125) in human plasma samples using a novel immunoassay based on silver conductive nano-ink: A new platform in early stage diagnosis of ovarian cancer and efficient management.
    Jafari M; Hasanzadeh M; Solhi E; Hassanpour S; Shadjou N; Mokhtarzadeh A; Jouyban A; Mahboob S
    Int J Biol Macromol; 2019 Apr; 126():1255-1265. PubMed ID: 30615961
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum Human Epididymis Protein 4 is Associated with Renal Function and Diabetic Kidney Disease in Patients with Type 2 Diabetes Mellitus.
    Zhang M; Zhao B; Xie J; Liang Y; Yang Z
    Biomed Res Int; 2019; 2019():4831459. PubMed ID: 31815140
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HE4--a novel promising serum marker in the diagnosis of ovarian carcinoma.
    Langmár Z; Németh M; Vleskó G; Király M; Hornyák L; Bösze P
    Eur J Gynaecol Oncol; 2011; 32(6):605-10. PubMed ID: 22335019
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.